This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Chengyao Tian: Innovator in Pharmaceutical Development
Introduction
Chengyao Tian is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds.
Latest Patents
Chengyao Tian holds a patent for a crystal form of tenofovir prodrug, which includes a preparation method and a method of use. The patent describes a crystal form of 9-[(R)-2-[[(S)-[[[1-(isopropoxycarbonyl)-1-methyl]ethyl]amino]phenoxyphosphinyl]methoxyl]propyl]adenine fumarate. This crystal form is characterized by an X-ray powder diffraction (XRPD) spectrum with specific diffraction peaks, indicating its unique properties. The crystal form boasts high bioavailability, significant efficacy, good stability, high yield, and high purity. These attributes contribute to improved drug production quality and assist in the design of drug administration routes.
Career Highlights
Chengyao Tian is affiliated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where he continues to innovate in pharmaceutical research and development. His work has been instrumental in advancing the quality of drug formulations and enhancing therapeutic outcomes.
Collaborations
Chengyao Tian collaborates with esteemed colleagues, including Ming Chen and Mingli Zhao, to further his research and development efforts in the pharmaceutical industry.
Conclusion
Chengyao Tian's contributions to pharmaceutical innovations, particularly through his patented work, highlight his role as a key figure in enhancing drug formulations. His ongoing efforts continue to impact the field positively.